3,037
Participants
Start Date
April 20, 2015
Primary Completion Date
October 14, 2016
Study Completion Date
October 14, 2016
Acetylsalicylic acid
ASA 100 mg enteric-coated tablet once daily orally.
Rivaroxaban
Rivaroxaban 2.5 mg tablet twice daily orally.
Clopidogrel
Clopidogrel 75 mg once daily orally.
Ticagrelor
Ticagrelor 90 mg twice daily orally.
Alexander City
Banning
Sylmar
Aurora
Littleton
Jupiter
Miami
Orlando
Pensacola
Tampa
Athens
Cumming
Macon
Tucker
Boise
Coeur d'Alene
Jerseyville
Indianapolis
Munster
Bay City
Kalamazoo
Lansing
Mount Clemens
Ypsilanti
Minneapolis
Columbia
St Louis
Kalispell
Stony Brook
Rocky Mount
Sanford
Cincinnati
Zanesville
Bartlesville
Tulsa
Abington
Langhorne
Philadelphia
Sayre
York
Rapid City
Oak Ridge
Amarillo
Fort Sam Houston
Houston
Odessa
San Antonio
Danville
Puyallup
Buenos Aires
Caba
Ciudad de Buenos Aires
Cordooba
Corrientes
Córdoba
La Plata
Mar del Plata
Resistencia
Rosario
Salta
San Martín
Santa Fe
Brisbane
Cairns
Chermside
Elizabeth Vale
Herston
Hobart
Launceston
Liverpool
Murdoch
Nambour
New Lambton Heights
Antwerp
Bonheiden
Brasschaat
Bruges
Edegem
Genk
Ghent
Huy
Liège
Mol
Roeselare
Ronse
Turnhout
Belo Horizonte
Blumenau
Campina Grande do Sul
Campinas
Curitiba
Marília
Passo Fundo
Porto Alegre
Recife
Salvador
São José do Rio Preto
São Paulo
Tatuí
Uberlândia
Votuporanga
Blagoevgrad
Burgas
Haskovo
Lovech
Pazardzhik
Pleven
Rousse
Sandanski
Sofia
Varna
Edmonton
New West Minister
Victoria
Greater Sudbury
London
Newmarket
Toronto
Montreal
Saint-Charles-Borromée
Sherbrooke
Québec
Brno
Kolin Iii.
Ostrava
Plzen-Bory
Prague
Třebíč
Znojmo
Herlev
Køge
Silkeborg
Besançon
Chambray-lès-Tours
Jossigny
Le Coudray
Lyon
Montauban
Nantes
Périgueux
Balatonfüred
Budapest
Debrecen
Győr
Gyula
Kaposvár
Kecskemét
Nyíregyháza
Székesfehérvár
Szolnok
Gifu
Kagawa
Kitakyushu
Kobe
Kumamoto
Matsue
Nagano
Osaka
Sayama-Shi
Tokyo
Uwajima-Shi
Yokohama
Yonago
Yotsui 2-8-1
's-Hertogenbosch
Amersfoort
Amsterdam
Blaricum
Den Helder
Gouda
Groningen
Hoofddorp
Hoogeveen
Nijmegen
Rotterdam
Schiedam
The Hague
Bielsko-Biala
Bytom
Chrzanów
Dąbrowa Górnicza
Gdynia
Grodzisk Mazowiecki
Inowrocław
Kędzierzyn-Koźle
Kielce
Koszalin
Krakow
Lodz
Nowy Targ
Nysa
Oświęcim
Polanica-Zdrój
Puławy
Tychy
Warsaw
Włocławek
Barnaul
Chita
Ivanovo
Kaliningrad
Kemerovo
Krasnodar
Krasnoyarsk
Moscow
Nizhny Novgorod
Orenburg
Penza
Perm
Rostov-on-Don
Saint Petersburg
Samara
Syktyvkar
Tyumen
Yekaterinburg
Gwangju
Incheon
Seongnam
Seoul
Suwon
A Coruña
Almería
Ávila
Barcelona
Madrid
Málaga
Murcia
Sant Boi de Llobregat
Tarragona
Falun
Jönköping
Linköping
Lund
Örebro
Östersund
Stockholm
Sundsvall
Uppsala
Adana
Ankara
Aydin
Bursa
Diyarbakır
Eskişehir
Istanbul
Kahramanmaraş
Kocaeli
Konya
Sivas
Cherkasy
Dnipropetrovsk
Kharkiv
Kyiv
Lutsk
Lviv
Odesa
Ternopil
Zaporizhzhia
Zhytomyr
Collaborators (2)
Bayer
INDUSTRY
Duke Clinical Research Institute
OTHER
Harvard Medical School (HMS and HSDM)
OTHER
Janssen Research & Development, LLC
INDUSTRY